Literature DB >> 35279785

Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages.

Selin Engür-Öztürk1, Miriş Dikmen2.   

Abstract

BACKGROUND: Lung cancer is a leading cause of cancer-related deaths, primarily as a result of metastases. In this metastasis, the epithelial-to-mesenchymal transition (EMT) is essential. Interaction with the cancer cell microenvironment is primarily dependent on M1- and M2-polarized macrophage. METHODS AND
RESULTS: In this study, we revealed the EMT-associated activity of M1, M2a and M2c macrophages in A549 lung cancer cells. We established a co-culture model of A549 lung cancer cells utilizing THP-1-derived M1/M2 polarised macrophages to explore the involvement of macrophages in the immune response, apoptosis, and EMT in lung cancer. Although multiple polarising agents are routinely used for M1 and M2 conversion, we assessed a new possible polarising agent, hydrocortisone.
CONCLUSIONS: M1 increased A549 cell sensitivity to proteasome inhibitors and decreased A549 cell viability by inducing apoptosis. EMT was induced in the presence of M2c macrophages in A549 cells by the levels of vimentin, fibronectin, E-cadherin, NF-kB, CCL-17. We also revealed the antiproliferative effects of bortezomib and ixazomib on A549 cells in both 2D and 3D cultures. Our findings could help develop an immunotherapeutic strategy by shedding light on a previously undiscovered part of the EMT pathway. Furthermore, additional investigation may reveal that polarising tumour-associated macrophages to M1 and eliminating the M2a or particularly the M2c subtype are effective anti-cancer strategies.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  A549; Bortezomib; EMT; Ixazomib; Macrophages; NF-kB

Mesh:

Substances:

Year:  2022        PMID: 35279785     DOI: 10.1007/s11033-022-07329-w

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  33 in total

Review 1.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  Characterization of a CSF-induced proliferating subpopulation of human peripheral blood monocytes by surface marker expression and cytokine production.

Authors:  M Finnin; J A Hamilton; S T Moss
Journal:  J Leukoc Biol       Date:  1999-12       Impact factor: 4.962

3.  Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation.

Authors:  Frank A W Verreck; Tjitske de Boer; Dennis M L Langenberg; Linda van der Zanden; Tom H M Ottenhoff
Journal:  J Leukoc Biol       Date:  2005-12-05       Impact factor: 4.962

4.  M-1/M-2 macrophages and the Th1/Th2 paradigm.

Authors:  C D Mills; K Kincaid; J M Alt; M J Heilman; A M Hill
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

Review 5.  Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.

Authors:  Douglas S Micalizzi; Susan M Farabaugh; Heide L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-19       Impact factor: 2.673

6.  A novel phenotype for an activated macrophage: the type 2 activated macrophage.

Authors:  Charles F Anderson; David M Mosser
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

Review 7.  Lung cancer.

Authors:  Alesha A Thai; Benjamin J Solomon; Lecia V Sequist; Justin F Gainor; Rebecca S Heist
Journal:  Lancet       Date:  2021-07-14       Impact factor: 79.321

Review 8.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

Review 9.  Tumor microenvironment: a new treatment target for cancer.

Authors:  Ming-Ju Tsai; Wei-An Chang; Ming-Shyan Huang; Po-Lin Kuo
Journal:  ISRN Biochem       Date:  2014-04-10

10.  Human breast cancer cells educate macrophages toward the M2 activation status.

Authors:  Sofia Sousa; Régis Brion; Minnamaija Lintunen; Pauliina Kronqvist; Jouko Sandholm; Jukka Mönkkönen; Pirkko-Liisa Kellokumpu-Lehtinen; Susanna Lauttia; Olli Tynninen; Heikki Joensuu; Dominique Heymann; Jorma A Määttä
Journal:  Breast Cancer Res       Date:  2015-08-05       Impact factor: 6.466

View more
  1 in total

1.  Screening and identification of HTNVpv entry inhibitors with high-throughput pseudovirus-based chemiluminescence.

Authors:  Xiaojing Wen; Li Zhang; Qiang Liu; Xinyue Xiao; Weijin Huang; Youchun Wang
Journal:  Virol Sin       Date:  2022-05-02       Impact factor: 6.947

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.